FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Nonresident Sterile Compounding Renewal
October 23, 2020

Click here to view the full requirements for the Nonresident Sterile Compounding renewal for Nonresident Pharmacies and Outsourcing Facilities. Continue reading


Pharmacists and Interns May Administer Childhood and COVID-19 Vaccines
October 2, 2020

Emergency Order DOH No. 20-014 allows licensed pharmacists and registered pharmacy interns to administer FDA approved vaccines to individuals, including those under 18 years of age. Continue reading